THEMISMEDPharmaceuticals
Themis Medicare Ltd — Cash Flow Statement
₹66.07
-9.59%
Themis Medicare Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 19.28 Cr | 3.68 Cr | -12.66 Cr | 13.77 Cr | — |
| Issuance Of Capital Stock | 0.00 | 0.04 Cr | 0.08 Cr | 0.40 Cr | — |
| Capital Expenditure | -15.43 Cr | -18.42 Cr | -28.75 Cr | -20.63 Cr | — |
| End Cash Position | 6.56 Cr | 9.92 Cr | 12.55 Cr | 20.28 Cr | — |
| Beginning Cash Position | 9.92 Cr | 12.55 Cr | 20.28 Cr | 19.02 Cr | — |
| Changes In Cash | -3.36 Cr | -2.62 Cr | -7.73 Cr | 1.26 Cr | — |
| Financing Cash Flow | -25.90 Cr | -8.77 Cr | 0.14 Cr | -17.55 Cr | — |
| Interest Paid Cff | -8.49 Cr | -7.63 Cr | -7.99 Cr | -6.54 Cr | — |
| Cash Dividends Paid | -4.60 Cr | -4.60 Cr | -4.60 Cr | -3.96 Cr | — |
| Net Common Stock Issuance | 0.00 | 0.04 Cr | 0.08 Cr | 0.40 Cr | — |
| Common Stock Issuance | 0.00 | 0.04 Cr | 0.08 Cr | 0.40 Cr | — |
| Net Issuance Payments Of Debt | -12.80 Cr | 3.84 Cr | 13.41 Cr | -6.61 Cr | — |
| Net Short Term Debt Issuance | -4.64 Cr | 5.51 Cr | 8.84 Cr | -8.29 Cr | — |
| Net Long Term Debt Issuance | -8.16 Cr | -1.67 Cr | 4.56 Cr | 1.69 Cr | — |
| Investing Cash Flow | -12.17 Cr | -15.95 Cr | -23.96 Cr | -15.59 Cr | — |
| Interest Received Cfi | 1.12 Cr | 0.84 Cr | 0.55 Cr | 0.61 Cr | — |
| Dividends Received Cfi | 0.43 Cr | 1.61 Cr | 4.21 Cr | 3.11 Cr | — |
| Net Investment Purchase And Sale | 0.02 Cr | 0.00 | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | -13.74 Cr | -18.39 Cr | -28.71 Cr | -19.30 Cr | — |
| Sale Of PPE | 1.68 Cr | 0.02 Cr | 0.03 Cr | 1.32 Cr | — |
| Purchase Of PPE | -15.43 Cr | -18.42 Cr | -28.75 Cr | -20.63 Cr | — |
| Operating Cash Flow | 34.71 Cr | 22.09 Cr | 16.09 Cr | 34.39 Cr | — |
| Taxes Refund Paid | -10.75 Cr | -8.96 Cr | -16.15 Cr | -18.07 Cr | — |
| Change In Working Capital | -5.11 Cr | -20.92 Cr | -40.30 Cr | -42.55 Cr | — |
| Change In Other Current Liabilities | 4.37 Cr | 3.03 Cr | 7.66 Cr | -14.62 Cr | — |
| Change In Other Current Assets | -1.41 Cr | 2.72 Cr | -4.05 Cr | -3.69 Cr | — |
| Change In Payable | 4.15 Cr | 7.25 Cr | 8.17 Cr | 1.08 Cr | — |
| Change In Inventory | -13.74 Cr | -1.62 Cr | -8.14 Cr | -2.31 Cr | — |
| Change In Receivables | 0.84 Cr | -32.92 Cr | -44.46 Cr | -22.95 Cr | — |
| Other Non Cash Items | 8.49 Cr | 7.63 Cr | 7.99 Cr | 6.54 Cr | — |
| Depreciation And Amortization | 9.93 Cr | 12.25 Cr | 10.49 Cr | 9.48 Cr | — |
| Depreciation | 9.93 Cr | 12.25 Cr | 10.28 Cr | 9.26 Cr | — |
| Gain Loss On Investment Securities | -1.51 Cr | -2.54 Cr | -4.81 Cr | -3.75 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 7000.00 | 72000.00 | -0.01 Cr | 0.00 | — |
| Gain Loss On Sale Of PPE | -0.09 Cr | -0.02 Cr | -0.02 Cr | -1.17 Cr | — |
| Net Income From Continuing Operations | 39.67 Cr | 53.44 Cr | 72.51 Cr | 95.26 Cr | — |
| Purchase Of Investment | — | 0.00 | 0.00 | 0.00 | — |
| Amortization Cash Flow | — | 0.22 Cr | 0.22 Cr | 0.22 Cr | 0.22 Cr |
| Gain Loss On Sale Of Business | — | 0.00 | 1000.00 | 0.00 | — |
| Repayment Of Debt | — | — | — | — | -19.69 Cr |
| Issuance Of Debt | — | — | — | — | 7.26 Cr |
| Net Other Financing Charges | — | — | — | — | 1000.00 |
| Short Term Debt Payments | — | — | — | — | -19.69 Cr |
| Long Term Debt Issuance | — | — | — | — | 7.26 Cr |
| Provisionand Write Offof Assets | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Themis Medicare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.